Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 33-40

  Blanchard, Pierre ^a   Baujat, Bertrand ^b   Holostenco, Victoria ^a   Bourredjem, Abderrahmane ^a   Baey, Charlotte ^a   Bourhis, Jean ^a   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Chemotherapy; Head and neck cancer; Hypopharynx; Individual patient data; Larynx; Meta analysis; Oral cavity; Oropharynx; Radiotherapy; Randomized clinical trials; Systematic review

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX TUMOR; LARYNX TUMOR; META ANALYSIS; OROPHARYNX TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 80051789292     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.036     Document Type: Article

References (21)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr.
2. J.P. Pignon, J. Bourhis, C. Domenge, and L. Designe Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 2000 949 955 (Pubitemid 30148259)
3. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients Radiother Oncol 92 2009 4 14
4. A. Bleyer Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement Semin Oncol 36 2009 451 459
5. L. Hammarstedt, H. Dahlstrand, and D. Lindquist The incidence of tonsillar cancer in Sweden is increasing Acta Otolaryngol 127 2007 988 992 (Pubitemid 47345807)
6. P. Lassen The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol 95 2010 371 380
7. S. Furness, A.M. Glenny, and H.V. Worthington Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy Cochrane Database Syst Rev 4 2011 CD006386
8. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346 (Pubitemid 26342716)
9. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371 (Pubitemid 15107153)
10. Non-mall Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
11. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558 (Pubitemid 34746062)
12. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15.
13. S. Michiels, B. Baujat, C. Mahe, D.J. Sargent, and J.P. Pignon Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses J Clin Epidemiol 58 2005 238 245 (Pubitemid 40249465)
14. L. Talarico, G. Chen, and R. Pazdur Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration J Clin Oncol 22 2004 4626 4631 (Pubitemid 41185131)
15. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715 (Pubitemid 350005152)
16. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704 (Pubitemid 350005151)
17. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
18. S. Michiels, A. Le Maitre, and M. Buyse Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data Lancet Oncol 10 2009 341 350
19. J. Overgaard Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - a systematic review and meta-analysis Radiother Oncol 100 2011 22 32
20. Zackrisson B, Nilsson P, Kjellén E, et al. Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - the ARTSCAN study. Radiother Oncol. 2011 Feb 3. [Epub ahead of print].
21. V. Loimu, J. Collan, and L. Vaalavirta Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin Radiother Oncol 98 2011 34 37